A novel polynucleotide involved in heritable Parkinson's disease

Details for Australian Patent Application No. 2005319787 (hide)

International Classifications

Event Publications

19 July 2007 PCT application entered the National Phase

PCT publication WO2006/068492 Priority application(s): WO2006/068492

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

18 August 2011 Section 223 Application Received

Aasly, J.; Farrer, M.; Wszolek, Z. An application to extend the time from 19 Dec 2010 to 19 Aug 2011 in which to pay a continuation fee has been filed . Address for service in Australia - Callinans 1193 Toorak Road Camberwell VIC 3124 2009

6 October 2011 Section 223 Application Allowed

Aasly, J.; Farrer, M.; Wszolek, Z. The time in which to pay a continuation fee has been extended to 19 Aug 2011. Address for service in Australia - Callinans 1193 Toorak Road Camberwell VIC 3124 2006

13 October 2011 Assignment before Grant

Aasly, Jan; Wszolek, Zbigniew; Farrer, Matthew The application has been assigned to Aasly, Jan; Mayo Foundation for Medical Education and Research 2006

1 December 2011 Application Accepted

Published as AU-B-2005319787

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.